[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350272-105":59,"doc-detail-350272-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","emerging-nanoimmunotherapeutic-strategies-for-breast-cancer","Emerging nanoimmunotherapeutic strategies for breast cancer","","Breast cancer is among the most prevalent forms of cancer, with management traditionally relying on surgery, radiation, and chemotherapy. Advances in understanding breast cancer pathobiology have accelerated interest in immunotherapy, especially nanotechnology-enabled approaches that connect tumor immunology with nanomedicine. A narrative review highlights lipid nanoparticles, polymeric nanoparticles, inorganic nanomaterials, virus-like particles, and extracellular vesicle-based systems that can modulate anti-tumor immune responses, address delivery and immune regulation constraints, and support biomarker-guided combination nano-immunotherapy directions.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-nanoimmunotherapeutic-strategies-for-breast-cancer/350272/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-nanoimmunotherapeutic-strategies-for-breast-cancer/350272.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"How do nanomedicines improve immunotherapy outcomes?","Question",{"text":112,"@type":113},"Nanomedicines enable targeted delivery of immunotherapeutic agents to tumor sites using nanoscale materials. They can improve efficacy while reducing side effects by maximizing therapeutic impact and helping overcome limitations in agent delivery and immune modulation.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},350272,1790123714,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":131,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":132,"faqs":133,"seo_title":134,"seo_description":67,"update_tm":135,"read_time":136,"preview_page_count":19,"preview_urls":137},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Panzade etal. Discover Oncology (2026) 17:732 [https://doi.org/10.1007/s12672-026-04894-5](https://doi.org/10.1007/s12672-026-04894-5)  \nDiscover Oncology  \nREVIEW Open Access  \nEmerging nanoimmunotherapeutic strategies  for breast cancer  \nGauri Panzade1†, Atharva Anand Mahajan1†, Siva Parsad Panda2, Ujjayita Chowdhury1, Rohit Krishnan Iyer 1, Subhrojyoti Ghosh3,4, Madhurima Koley5, Akanksha Bhattacharya6, Avishek Chatterjee4, Anuvab Dey7, Chandrika Sarkar4, Ankita Chowdhury8, Bhaskarjyaa Chatterjee9, Souvadra Das 10, Shrimanti Das 11, Souhardya Bandyopadhyay12, Ramya Lakshmi Rajendran 13,14,15*, Prakash Gangadaran14,15*,  \nByeong-Cheol Ahn13,14,15,16* and Saurabh Kumar Jha17,18*  \n†Gauri Panzade and Atharva Anand Mahajan have equally contributed to this work.  \n*Correspondence:  \nRamya Lakshmi Rajendran[ramyag@knu.ac.kr](ramyag@knu.ac.kr)[ ](ramyag@knu.ac.kr)Prakash Gangadaran [prakashg@knu.ac.kr](prakashg@knu.ac.kr)[ ](prakashg@knu.ac.kr)Byeong-Cheol Ahn [abc2000@knu.ac.kr](abc2000@knu.ac.kr)[ ](abc2000@knu.ac.kr)Saurabh Kumar Jha [Jhasaurabh017@gmail.com](Jhasaurabh017@gmail.com)  \nFull list of author information is available at the end of the article  \nAbstract  \nBreast cancer is among the most prevalent forms of cancer. The conventional modalities employed in the management of breast cancer include mainly surgery, radiation, and chemotherapy. The enhanced comprehension of the complex pathobiology of breast cancer has resulted in the emergence of immunotherapy as a highly auspicious therapeutic approach. This is a narrative review focusing on nanotechnology-enabled immunotherapy strategies for breast cancer, at the interface of tumor immunology and nanomedicine. We highlight lipid nanoparticles, polymeric nanoparticles, inorganic nanomaterials, virus-like particles, and extracellular vesiclebased systems that modulate the anti-tumor immune response. Immunotherapy stimulates the patient's immune system to selectively recognize and eliminate cancerous cells. The present methodology focuses on the primary molecular constituents of neoplastic tissue and offers a potentially novel therapeutic strategy. Comprehending the intricate interplay between neoplastic cells and immunological components is paramount for devising efficacious therapeutic interventions. Immunotherapy can not only eliminate tumors but also be proven effective in impeding metastasis and recurrence. The implementation of immunotherapy in clinical settings has encountered certain constraints, such as weak immune responses resulting from insufficient delivery of immunostimulants to target cells and unregulated modulation of the immune system, leading to the development of autoimmunity and non-specific inflammation. Nanomedicines offer a unique opportunity to maximize the efficacy of immunotherapy and significantly reduce its side effects. The present article discusses the latest developments in breast cancer immunotherapy involving nanotechnology. These advancements encompass a range of approaches, including the direct stimulation of the immune system via the administration of tumor antigens and adjuvants to immune cells, the modification of the tumor microenvironment to reduce immunosuppression, and integration with other therapeutic modalities. We summarise current evidence, identify  \ncritical knowledge gaps, and outline future directions for biomarker-guided and combination nano-immunotherapy trials in breast cancer.  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. T","cbCaiqAtmZ83nsLM","https://ap.wps.com/l/cbCaiqAtmZ83nsLM","pdf",2041960,"English","# Abstract\n# Introduction\n## Clinical challenges in breast cancer management\n## Rationale for immunotherapy and its limitations\n## Role of nanotechnology in targeted immunotherapy\n# Keywords","[{\"question\":\"How do nanomedicines improve immunotherapy outcomes?\",\"answer\":\"Nanomedicines enable targeted delivery of immunotherapeutic agents to tumor sites using nanoscale materials. They can improve efficacy while reducing side effects by maximizing therapeutic impact and helping overcome limitations in agent delivery and immune modulation.\"}]","Emerging nanoimmunotherapeutic strategies for breast cancer | PDF",1790088187,76,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f084ae83f3370111f100489bc24a552.webp",983,1310,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed244530c54ce1d184855e3ab13ab4a6.webp",982,1309,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aca7098f586d2684983e6f7ccf16d5d8.webp",981,1308,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/412389b6914212b5ad167f0ace14d7be.webp",980,1306]